Spots Global Cancer Trial Database for AssesSment of Early-deteCtion basEd oN liquiD Biopsy in GASTRIC Cancer, ASCEND-Gastric
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: AssesSment of Early-deteCtion basEd oN liquiD Biopsy in GASTRIC Cancer, ASCEND-Gastric
Official Title: Gastric Cancer Detection by Liquid Biopsy in Peripheral Blood: A Prospective Study
Study ID: NCT05224596
Conditions
Interventions
Study Description
Brief Summary: ASCEND-Gastric is a prospective, multi-omics, observational study aimed at detecting gastric cancer by combined assays for serum protein markers, deep sequencing of cell-free DNA (cfDNA), circulating tumor DNA (ctDNA) mutation and circulating RNA. The study will enroll 498 participants, including 128 patients with benign gastric diseases and 370 patients with gastric cancer.
Detailed Description:
Eligibility
Minimum Age: 40 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
ZhongShan hospital FuDan university, Shanghai, Shanghai, China
Contact Details
Name: Yihong Sun Sun, MD
Affiliation: Zhongshan Hospital, Fudan University,China
Role: PRINCIPAL_INVESTIGATOR
Name: Xuefei Wang, MD
Affiliation: Zhongshan Hospital, Fudan University,China
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
